Confirmation of the H5N1 strain comes after the virus was detected last week at an Indiana turkey farm.
People who received a different brand of COVID-19 vaccine booster than they did in the primary series had lower rates of infection than those who received the same brand, according to a study in Singapore published late last week in JAMA.
An analysis conducted at hospitals in Michigan found that the more antibiotic stewardship strategies a hospital reported, the lower its overuse of antibiotics at discharge, researchers reported yesterday in Clinical Infectious Diseases.
A study in Qatar estimates that previous COVID-19 infection imparts 56% protection against future symptomatic infection caused by the highly transmissible Omicron variant, down from about 90% for other SARS-CoV-2 strains.
The study, published yesterday in the New England Journal of Medicine (NEJM), was led by researchers at Weill Cornell Medicine–Qatar in Doha.
The detection marks the first appearance of high-path avian flu in US poultry since 2020.
A small Massachusetts General Hospital–based study in JAMA shows more lasting antibodies in infants after COVID-19 vaccination during pregnancy, compared with infants whose mothers had natural COVID-19 infections during pregnancy but were not vaccinated.
Chronic wasting disease (CWD) has been confirmed for the first time in Louisiana, the Louisiana Department of Wildlife and Fisheries (LDWF) said late last week.
A 3-year prospective audit and feedback (PAF) intervention led by pharmacists at a Japanese hospital was linked to reduced antibiotic duration and more appropriate antibiotic use in patients with Escherichia coli bacteremia, Japanese researchers reported yesterday in the American Journal of Infection Control.
A multifaceted antibiotic stewardship strategy implemented in three emergency departments (EDs) was associated with an increase in guideline-concordant antibiotic choices for patients with urinary tract infections (UTIs), researchers reported today in Clinical Infectious Diseases.
Significantly fewer adult Medicare beneficiaries with schizophrenia or bipolar 1 disorders had mental health-related outpatient, emergency department (ED), and hospital visits, as well as fills for antipsychotics and mood-stabilizing drugs in the first 8 months of the COVID-19 pandemic.
